Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...
Medical device software company Voluntis has received an updated FDA clearance (as well as an updated CE mark) for its Insulia app, a "digital companion" app for people with Type 2 diabetes. Insulia ...
(RTTNews) - DexCom, Inc. (DXCM) on Wednesday announced that the U.S. Food and Drug Administration (FDA) has cleared Dexcom Smart Basal, the first and only continuous glucose monitor (CGM)-integrated ...
May 18, 2009 — Patients with type 2 diabetes who need to receive insulin can be successfully taught to adjust their basal insulin dose for themselves and improve their glycemic control, according to ...
Many people with type 2 diabetes need insulin therapy to help manage their blood sugar levels. If you need insulin therapy, starting it sooner rather than later can help lower your risk of ...
Insulin dosage is an ongoing area of interest among digital health companies. Initiating and increasing insulin dosages represent some of the greatest challenges to help Type 2 diabetes patients ...
In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a second ...
Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin. Dexcom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results